documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
54 rows where docket_id = "FDA-2000-D-0187" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 54
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-D-0187-0052 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 5 - Malaria _ CDC Yellow Book 2024 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:21Z | 0 | 0 | 09000064868c15dc | |||
| FDA-2000-D-0187-0057 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 10 - Mungai M | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:56:15Z | 0 | 0 | 09000064868c15e1 | |||
| FDA-2000-D-0187-0053 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 6 - Local Transmission of I Plasmodium vivax I Malaria --- Palm Beach County Florida 2003 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:34Z | 0 | 0 | 09000064868c15dd | |||
| FDA-2000-D-0187-0065 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 18 - Khan J | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:36Z | 0 | 0 | 09000064868c15f5 | |||
| FDA-2000-D-0187-0072 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry | Other | Guidance | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T05:00:00Z | 2025-03-18T03:59:59Z | 2025-03-22T01:00:44Z | 1 | 0 | 09000064868c694a | |
| FDA-2000-D-0187-0050 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 3 - Doolan D | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:01Z | 0 | 0 | 09000064868c156b | |||
| FDA-2000-D-0187-0062 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 15 - Stubbs L | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:09Z | 0 | 0 | 09000064868c15f2 | |||
| FDA-2000-D-0187-0064 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 17 - Dike A | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:27Z | 0 | 0 | 09000064868c15f4 | |||
| FDA-2000-D-0187-0056 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 9 - Muneer A | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:56:04Z | 0 | 0 | 09000064868c15e0 | |||
| FDA-2000-D-0187-0049 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 2 - World Malaria Report 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:54:49Z | 0 | 0 | 09000064868c156a | |||
| FDA-2000-D-0187-0070 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 23 Malaria Surveillance United States 2016 MMWR | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:58:21Z | 0 | 0 | 09000064868c161c | |||
| FDA-2000-D-0187-0051 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 4 - Mace K | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:11Z | 0 | 0 | 09000064868c15db | |||
| FDA-2000-D-0187-0059 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 12 - Uneke C | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:56:37Z | 0 | 0 | 09000064868c15e3 | |||
| FDA-2000-D-0187-0063 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 16 - Neiderhauer C | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:18Z | 0 | 0 | 09000064868c15f3 | |||
| FDA-2000-D-0187-0061 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 14 - Anand A | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:56:57Z | 0 | 0 | 09000064868c15f1 | |||
| FDA-2000-D-0187-0054 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 7 - Blackburn D | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:44Z | 0 | 0 | 09000064868c15de | |||
| FDA-2000-D-0187-0066 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 19 - Israelyan N | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:46Z | 0 | 0 | 09000064868c15f6 | |||
| FDA-2000-D-0187-0048 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 1 -Guidance for Industry. Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:54:30Z | 0 | 0 | 09000064868c1569 | |||
| FDA-2000-D-0187-0055 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 8 - Duwell M | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:55:54Z | 0 | 0 | 09000064868c15df | |||
| FDA-2000-D-0187-0071 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference-24 Malaria Surveillance United States 2017 MMWR | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:58:29Z | 0 | 0 | 09000064868c161d | |||
| FDA-2000-D-0187-0069 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 22-MalariaRBDMAnalysis_FINAL_2024-05-28 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:58:13Z | 0 | 0 | 09000064868c15f9 | |||
| FDA-2000-D-0187-0060 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 13 - Katz L | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:56:49Z | 0 | 0 | 09000064868c15e4 | |||
| FDA-2000-D-0187-0068 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 21- Blood Products Advisory Committee May 9.. | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:58:04Z | 0 | 0 | 09000064868c15f8 | |||
| FDA-2000-D-0187-0067 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference 20 - cobas Malaria _ FDA | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:57:55Z | 0 | 0 | 09000064868c15f7 | |||
| FDA-2000-D-0187-0047 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | References | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T16:54:14Z | 0 | 0 | 09000064868c1568 | |||
| FDA-2000-D-0187-0046 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-01-16T05:00:00Z | 2025-01-24T18:59:15Z | 2025-01028 | 0 | 0 | 09000064868c6752 | |
| FDA-2000-D-0187-0058 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Malaria Guidance 2024-434 | Supporting & Related Material | 2025-01-16T00:00:00Z | 2025 | 1 | 2025-01-16T17:11:32Z | 0 | 1 | 09000064868c15e2 | ||||
| FDA-2000-D-0187-0044 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability | Notice | Notice of Availability | 2022-12-08T05:00:00Z | 2022 | 12 | 2022-12-08T05:00:00Z | 2022-12-08T15:46:19Z | 2022-26711 | 0 | 0 | 0900006485524919 | |
| FDA-2000-D-0187-0045 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry - Final Guidance | Other | Guidance | 2022-12-08T05:00:00Z | 2022 | 12 | 2022-12-08T05:00:00Z | 2024-11-07T00:45:38Z | 1 | 0 | 090000648552199f | ||
| FDA-2000-D-0187-0031 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 4 Mace KE et al - MMWR 2017 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:06Z | 0 | 0 | 09000064846f6952 | |||
| FDA-2000-D-0187-0030 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 3 - OBrien SF - Transfusion medicine reviews 2015 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:01:54Z | 0 | 0 | 09000064846f6951 | |||
| FDA-2000-D-0187-0043 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 15 FDA BPAC Transcripts 111609 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:05:11Z | 0 | 0 | 09000064846f69b0 | |||
| FDA-2000-D-0187-0026 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Other | Guidance | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T04:00:00Z | 2022-12-08T15:47:25Z | 0 | 0 | 09000064846f6586 | ||
| FDA-2000-D-0187-0027 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference List Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:00:39Z | 0 | 0 | 09000064846f658e | |||
| FDA-2000-D-0187-0039 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 11 Doolan D L et al Acquired immunity to malaria Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:15Z | 0 | 0 | 09000064846f69ac | |||
| FDA-2000-D-0187-0033 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 5 - Mace KE et al - MMWR 2018Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:37Z | 0 | 0 | 09000064846f697e | |||
| FDA-2000-D-0187-0036 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 8 - Reesink et al - Transfusion 2010 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:23Z | 0 | 0 | 09000064846f6981 | |||
| FDA-2000-D-0187-0041 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 13 FDA Workshop Testing for malarial infections in blood donors July 12 2006 FDA Blood Products Advisory Committee Testing for malarial infections in blood donors July 13 2006 | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:50Z | 0 | 0 | 09000064846f69ae | |||
| FDA-2000-D-0187-0029 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 2 - Mungai M et al - NEJM 2001 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:01:44Z | 0 | 0 | 09000064846f6950 | |||
| FDA-2000-D-0187-0035 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 7 Spencer B et al Risk for malaria in United States donors deferred for travel to malaria endemic areas Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:14Z | 0 | 0 | 09000064846f6980 | |||
| FDA-2000-D-0187-0032 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 5 - Mace KE et al - MMWR 2018 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:16Z | 0 | 0 | 09000064846f6953 | |||
| FDA-2000-D-0187-0034 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 6 - Mace KE et al - MMWR 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:00Z | 0 | 0 | 09000064846f697f | |||
| FDA-2000-D-0187-0037 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 9 - Spenser B et al - Transfusion Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:35Z | 0 | 0 | 09000064846f6982 | |||
| FDA-2000-D-0187-0042 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 14 FDA Blood Products Advisory Committee - Sept 2008 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:05:00Z | 0 | 0 | 09000064846f69af | |||
| FDA-2000-D-0187-0038 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 10 Liljander A et al Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum in-1 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:48Z | 0 | 0 | 09000064846f6983 | |||
| FDA-2000-D-0187-0028 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 1 - Katz LM & Spenser BR - AABB Press 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:00:59Z | 0 | 0 | 09000064846f694f | |||
| FDA-2000-D-0187-0025 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T04:00:00Z | 2020-06-17T13:13:25Z | 2020-13066 | 0 | 0 | 09000064846f5e19 | |
| FDA-2000-D-0187-0040 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 12 - Nguyen ML et al - Transfusion 2013 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:26Z | 0 | 0 | 09000064846f69ad | |||
| FDA-2000-D-0187-0024 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Guidance for Industry | Other | Guidance | 2020-04-03T04:00:00Z | 2020 | 4 | 2020-04-03T04:00:00Z | 2024-11-06T23:34:52Z | 1 | 0 | 0900006484485685 | ||
| FDA-2000-D-0187-0021 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Guidance for Industry: Recommendations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria; Availability | Notice | Notice of Availability | 2013-08-19T04:00:00Z | 2013 | 8 | 2013-08-19T04:00:00Z | 2013-08-19T14:42:09Z | 2013-19962 | 0 | 0 | 09000064813b8a55 | |
| FDA-2000-D-0187-0022 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria: Guidance for Industry | Other | Guidance | 2013-08-01T04:00:00Z | 2013 | 8 | 2013-08-01T04:00:00Z | 2022-12-08T15:47:42Z | 0 | 0 | 09000064813b9117 | ||
| FDA-2000-D-0187-0003 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Draft Guidance for Industry Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria | Other | Guidance | 2012-07-06T04:00:00Z | 2012 | 7 | 2012-07-06T04:00:00Z | 2012-09-05T03:59:59Z | 2024-11-07T22:45:32Z | 1 | 0 | 090000648107d6f4 | |
| FDA-2000-D-0187-0002 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Draft Guidance for Industry:Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria; Availability | Notice | Notice of Data Availability | 2012-07-06T04:00:00Z | 2012 | 7 | 2012-07-06T04:00:00Z | 2012-09-05T03:59:59Z | 2012-09-07T02:01:07Z | 2012-16528 | 0 | 0 | 090000648107d34d |
| FDA-2000-D-0187-0001 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | FDA | Notice | NAD-Notice of Availability of Data | 2000-06-14T04:00:00Z | 2000 | 6 | 2000-06-14T04:00:00Z | 2000-09-07T03:59:59Z | 2008-04-25T01:14:48Z | 0 | 0 | 09000064804d2c71 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);